50 Years of progress in the systemic therapy of non-small cell lung cancer

Heather Wakelee, Karen Kelly, Martin J. Edelman

Research output: Contribution to journalArticlepeer-review

103 Scopus citations

Abstract

Non-small cell lung cancer constitutes 85% to 90% of lung cancer and is the most common cause of cancer death. Over the past 50 years, substantial progress has been made in all aspects of lung cancer including screening, diagnostic evaluation, surgery, radiation therapy, and chemotherapy. This review focuses on the advances in systemic therapy during this half century.

Original languageEnglish
Pages (from-to)177-189
Number of pages13
JournalAmerican Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Dive into the research topics of '50 Years of progress in the systemic therapy of non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this